Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Novartis is suing Regeneron for patent infringement over the manufacturing process used to produce its Eylea and Zaltrap eye treatments.
read more
Wednesday, April 03, 2019
Novartis has entered into an agreement and plan of merger with AveXis to acquire the US-based clinical stage gene therapy company for $218 per share or a total of $8.7 billion in cash.
read more
Novartis announced its commitment to donate up to 130 million doses of generic hydroxychloroquine to support the global COVID-19 pandemic response.
read more
Novartis will highlight the strength of its expanded oncology portfolio in 21 medicines and 11 investigational compounds across more than 185 data presentations at the upcoming American Society of Clinical Oncology (ASCO) Annual Meeting, May 29-June ...
read more
Wednesday, February 03, 2021
Novartis has signed an initial agreement to leverage its manufacturing capacity and capabilities in order to address the COVID-19 pandemic by supporting the production of the Pfizer-BioNTech COVID-19 Vaccine.
read more
Thursday, November 01, 2012
Novartis announced today the construction of a new state-of-the-art biotechnology production site in Singapore with an investment valued at over USD 500 million. The new facility will focus on drug substance manufacturing based on cell culture ...
read more
TriNetX has announced the signing of a collaboration agreement with Novartis to optimize clinical trial design and advance clinical research for Novartis programs.
read more
Monday, September 10, 2018
Novartis and Mundipharma, have signed an agreement for the marketing, sales and distribution of well-known pain medicine brands Voltaren and Cataflam in Malaysia, Thailand, and the Philippines.
read more
Novartis has announced that the Phase III study of Afinitor® (everolimus) tablets plus best supportive care in patients with advanced nonfunctional neuroendocrine tumors (NET) of gastrointestinal (GI) or lung origin met its primary endpoint.
read more
Wednesday, March 23, 2016
Novasep, a supplier of services and technologies for the life sciences industry, and GTP (Gene-to-Proteins) Technology, a CDMO providing recombinant protein and process development services, have announced a partnership that combines their expertise ...
read more
Wednesday, September 14, 2016
Novasep, a supplier of services and technologies for the life sciences industry, has announced a partnership with Triclinic Labs, Inc., a US-based provider of contract pharmaceutical and fine chemical solid-state development services.
read more
Novasep, a supplier of services and technologies for the life sciences industry, has announced the appointment of Xavier de Saint Guilhem as Chief Financial Officer.
nitially trained at ENSCP, MIT (Massachusetts Institute of Technology) and INSEAD, ...
read more
Novasep has announced a further expansion of its Highly Potent Active Pharmaceutical Ingredients manufacturing capabilities on its Le Mans site.
read more
Novasep, a supplier of services and technologies for the life sciences industry, announced a €6.1 million investment at its Mourenx facility(Pyrénées-Atlantiques – France). This investment will modernize its API manufacturing facility.
read more
Thursday, December 09, 2021
Novasep, a supplier of services and technologies for the life sciences industry, has announced a €6 million investment on its Chasse-sur-Rhône site, France (38). This investment will increase and modernize its manufacturing capabilities to support ...
read more